Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers
Zhen Dong, Muhammad Nadeem Abbas, Saima Kausar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3577-3577
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Photosynthetic and transcriptomic responses of Chlorella sp. to tigecycline
Qianru Zhao, Liying Zhu, Ling Jiang, et al.
Algal Research (2023) Vol. 71, pp. 103033-103033
Closed Access | Times Cited: 8
Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer
Yangyang Zhou, Siying Wang, Wei Wu, et al.
EBioMedicine (2022) Vol. 87, pp. 104397-104397
Open Access | Times Cited: 13
Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline
Xiang Li, Mengjiao Wang, Timo Denk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma
Alejandra Ortiz-Ruiz, Yanira Ruiz‐Heredia, María Luz Morales, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1662-1662
Open Access | Times Cited: 17
The Assessment of Anti-Melanoma Potential of Tigecycline—Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells
Jakub Rok, Justyna Kowalska, Zuzanna Rzepka, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1564-1564
Open Access | Times Cited: 6
Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.
Vishakha Anand Pawar, Anuradha Tyagi, Chaitenya Verma, et al.
PubMed (2023) Vol. 15, Iss. 8, pp. 4984-5006
Closed Access | Times Cited: 6
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
Kamil Kośmider, Katarzyna Karska, Agata Kozakiewicz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3795-3795
Open Access | Times Cited: 10
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
Giulio Donati, Micol Ravà, M. Filipuzzi, et al.
Molecular Oncology (2021) Vol. 16, Iss. 5, pp. 1132-1152
Open Access | Times Cited: 14
Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate – An example of breast cancer
Shu-Wei Huang, Ming-Tsung Sun, Wen‐Sen Lee, et al.
Journal of Microbiology Immunology and Infection (2021) Vol. 55, Iss. 1, pp. 51-59
Open Access | Times Cited: 11
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Physiological and transcriptomic analyses reveal the toxicological mechanism and risk assessment of environmentally-relevant waterborne tetracycline exposure on the gills of tilapia (Oreochromis niloticus)
Yi-Chuang Xu, Guang‐Hui Liu, Yi‐Huan Xu, et al.
The Science of The Total Environment (2021) Vol. 806, pp. 151290-151290
Closed Access | Times Cited: 10
Pharmacological Effects of Caffeic Acid and Its Derivatives in Cancer: New Targeted Compounds for the Mitochondria
Haydeé Bastidas, Gabriel Araya-Valdés, G. Cortés, et al.
Advances in experimental medicine and biology (2022), pp. 213-225
Closed Access | Times Cited: 7
Application of Plackett–Burman Design for Spectrochemical Determination of the Last-Resort Antibiotic, Tigecycline, in Pure Form and in Pharmaceuticals: Investigation of Thermodynamics and Kinetics
Ahmed S. El‐Shafie, Aseel Yousef, Marwa El‐Azazy
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 888-888
Open Access | Times Cited: 7
A novel antibacterial biomaterial mesh coated by chitosan and tigecycline for pelvic floor repair and its biological performance
Changyan Liang, You Ling, Feng Wei, et al.
Regenerative Biomaterials (2020) Vol. 7, Iss. 5, pp. 483-490
Open Access | Times Cited: 10
Rapid visualized assessment of drug efficacy in live mice with a selectable marker-free autoluminescent Klebsiella pneumoniae
Xirong Tian, Yamin Gao, Shuai Wang, et al.
Biosensors and Bioelectronics (2021) Vol. 177, pp. 112919-112919
Closed Access | Times Cited: 9
The effect of mitochondria inhibition on natural killer cells cytotoxicity in triple-negative breast cancer cells
S Khodaei, Shahbaz Sabetnam, Hojjatollah Nozad Charoudeh, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176106-176106
Closed Access | Times Cited: 3
Nanoparticle-Mediated Routing of Antibiotics into Mitochondria in Cancer Cells
Aman Bajpai, Nakshi Desai, Shalini Pandey, et al.
ACS Applied Bio Materials (2021) Vol. 4, Iss. 9, pp. 6799-6806
Closed Access | Times Cited: 8
<p>Effective Inhibition of <em>MYC</em>-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1</p>
Yang Zhao, Tiantian Li, Shuaiwei Tian, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 12473-12485
Open Access | Times Cited: 6
Effect of Invasion of Borrelia burgdorferi in Normal and Neoplastic Mammary Epithelial Cells
Gauri Gaur, Janhavi Y. Sawant, Ankita S. Chavan, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1295-1295
Open Access | Times Cited: 6
Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer
Versha Tripathi, Pooja Jaiswal, Khageswar Sahu, et al.
Advances in Cancer Biology - Metastasis (2022) Vol. 6, pp. 100065-100065
Open Access | Times Cited: 3
A Mitocentric View of the Main Bacterial and Parasitic Infectious Diseases in the Pediatric Population
Sonia Romero‐Cordero, Richard Kirwan, Antoni Noguera‐Julián, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3272-3272
Open Access | Times Cited: 4
Drug Repurposing Patent Applications October–December 2023
Hermann AM Mucke
Assay and Drug Development Technologies (2024) Vol. 22, Iss. 3, pp. 160-167
Closed Access
Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production
Carlos Ramos‐Acosta, Laura Huerta-Pantoja, Milton Eduardo Salazar-Hidalgo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4887-4887
Open Access
Investigating Mtr and MshC as potential targets in the fight against Mycobacterium abscessus infections
Tatiana Piller
(2024)
Open Access
Update About The Changes In Bacterial Resistance For Multiple Antibiotic In Patients With Urinary Tract Infection In Kerbala
Kawther Mohammed Radah Ali
Academia Open (2024) Vol. 9, Iss. 1
Closed Access

Scroll to top